EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 339 filers reported holding EXELIXIS INC in Q3 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,131,277 | +17.3% | 463,674 | +2.6% | 0.54% | +16.0% |
| Q2 2023 | $8,635,408 | -9.4% | 451,879 | -8.0% | 0.46% | -11.8% |
| Q1 2023 | $9,536,618 | +15.2% | 491,325 | -4.8% | 0.52% | +19.6% |
| Q4 2022 | $8,276,175 | +29.4% | 515,971 | +26.5% | 0.44% | +21.6% |
| Q3 2022 | $6,394,000 | -24.7% | 407,750 | -0.1% | 0.36% | -20.0% |
| Q2 2022 | $8,495,000 | -8.7% | 408,019 | -0.5% | 0.45% | +5.6% |
| Q1 2022 | $9,300,000 | +22.4% | 410,218 | -1.3% | 0.43% | +25.6% |
| Q4 2021 | $7,601,000 | -33.1% | 415,818 | -22.6% | 0.34% | -34.6% |
| Q3 2021 | $11,356,000 | +67.5% | 537,162 | +44.4% | 0.52% | +61.0% |
| Q2 2021 | $6,780,000 | -23.7% | 372,120 | -5.4% | 0.32% | -30.4% |
| Q1 2021 | $8,888,000 | – | 393,453 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |